# STOCKHOLM 1.0

#=GF AC   RF02694
#=GF ID   RalA
#=GF DE   RalR antitoxin
#=GF AU   Argasinska J; 0000-0003-2678-2824
#=GF SE   Argasinska J
#=GF SS   Predicted; PMID:24748661;
#=GF GA   170.00
#=GF TC   170.30
#=GF NC   47.30
#=GF TP   Gene; sRNA;
#=GF BM   cmbuild -F CM SEED
#=GF CB   cmcalibrate --mpi CM
#=GF SM   cmsearch --cpu 4 --verbose --nohmmonly -T 30.00 -Z 549862.597050 --mxsize
#=GF SM   128 CM SEQDB
#=GF DR   SO; 0000370; small_regulatory_ncRNA;
#=GF DR   GO; 0030371; translation repressor activity;
#=GF DR   GO; 0046677; response to antibiotic;
#=GF RN   [1]
#=GF RM   24748661
#=GF RT   RalR (a DNase) and RalA (a small RNA) form a type I toxin-antitoxin system
#=GF RT   in Escherichia coli.
#=GF RA   Guo Y, Quiroga C, Chen Q, McAnulty MJ, Benedik MJ, Wood TK, Wang X
#=GF RL   Nucleic Acids Res. 2014;42:6448-6462.
#=GF CC   Trans-encoded, has 16 nucleotides complimentary to coding region of toxin
#=GF CC   RalR mRNA. RalA functions as an antitoxin by preventing translation of
#=GF CC   RalR (a non-specific endonuclease that cleaves methylated and unmethylated
#=GF CC   DNA). Its activity requires RNA chaperone Hfq. RalR and RalA form a type I
#=GF CC   toxin-antitoxin (TA) system. RalR/RaLA TA locus is responsible for
#=GF CC   resistance to the antibiotic fosfomycin in E.coli.
#=GF WK   Escherichia_coli_sRNA
#=GF SQ   10



CP001396.1/1303639-1303817 GAGGACUGAAGUUUCUCGCAAUUAAAAUUUAUCAGUUUUACUUUCUGCUCUCUGGAAACGCCUGCUUCUUUUUUACCUGAGAGCAUUUUUUCGCAUUCUGAUUUCGUUAGUUUAGA-UUUUGAAUAUCUUGUCCAGUUAGUAGGAGUGCCACCUUCCUUUUCAAUAGUGGCGGUAAUUUU
AFDV01000042.1/40867-40689 GAGGACUGAAGUCUCUCGCAAUUAAAAUUUAUCAGUUUUACUUUCUGCUCUCUGGAAACGGCUGCUUCUUUUUUACCUGAGAGCAUUUUUUCGCAUUCUGAUUUCGUUAGUUUAGA-UUUUGAAUAUCUUGUCCAGUUAGUAGGAGUGCCACCUUCCUUUUCAAUAGUGGCGGUAAUUUU
ACXF01000026.1/92775-92953 GAGGACAGAAGUUUCUCGCAAUUAAAAUUUAUCAGUUUUACUUUCUGCUCUCUGGAAACGCCUGCUUCUUUUUUCCCUGAGAGCAUUUUUUCGCAUUCUGAUUUCGUUAAUUUAGA-UUUUGAAUAUCUUAUCCAGUUAGUAGGAGUGCCACCUUCUUUUUCAAUAGUGGCGGUAAUUUU
CP000266.1/1884764-1884586 GAGGACAGAAGUUUCUCGCAAUUAAAAUUUAUCAGUUUUACUUUCUGCUCUCUGGAAACGCCUGCUUCUUUUUUCCCUGAGAGCAUUUUUUCGCAUUCUGAUUUCGUUAGUUUAGA-UUUUGAAUAUCUUGUCCAGCUGGUAGGAGAACCACCUUCCUUUUCAAUAGUGGCUGUAAUUUU
AEZV01000092.1/20993-20815 GAGGACAGAAGUUUCUCGCAAUUAAAAUUUAUCAGCUUUACUUUCUGCUCUCUGGACACGCUUGCUUCUUUUUUCCCAGAGAGCAUUUUUUCGCAUUCUGAUUUCGUUAAUUUAGA-UUUUGAAUAUCUUGUCCAGUUAGUAGGAGUGCCACCUUCCUUUUCAAUAGUGGCAGUAAUUUU
AERQ01000013.1/21897-21719 GAGGACAGAAGUUUCUCGCAAUUAAAAUUUAUCAGCUUUACUUUCUGCUCUCUGGACACGCCUGCUUCUUUUUUCCCUGAGAGCAUUUUUUCGCAUUCUGAUUUCGUUAAUUUAGA-UUUUGAAUAUCUUGUCCAGUUAGUAGGAGUGCCACCUUCUUUUUCAAUAGUGGCAGUUAUUUU
AGTL01000342.1/5660-5482   GAGGACUGAAGUUGCUCGCAAUUAAAAUUUAUCAGUUUUACUUUCUGCUCUCUGGAAACGCCUGCUUCUUUUUUACCUGAGAGCAUUUUUUCGCAUUCUGAUUUGGUUAAUUUUGU-UUUUGAGUACCUUGUCCAGUUAGUAGGAGUGCCACCUUCCUUUUCAAUAGUGGCGGUAAUUUU
AFEA01000010.1/48077-47899 GACGACUGAAGUUUCUCGCAAUUAAAAUUUAUCAGUUUUACUUUCUGCUCUCUGGAAACGCCUGCUUCUUUUUUACCUGAGAGCAUUUUUUCGCAUUCUGAUUUGGUUAAUUUUGU-UUUUGAGUACCUUGUCCAGUUAGUAGGAGUGCCACCUUCCUUUUCAAUAGUGGCGGUAAUUUU
ADAV01000062.1/11136-10957 GAGGACAGAAGUUUCUCGCAAUUAAAAUUUAUCAGUUUUACUUUCUGCUCUCUGGAAACGCCUGCUUCUUUUUUCCCCGAGAGCAUUUUUUCGCAUUCCGAUUUGGUUAACUUUGUUUUUUGAGUACCUUGUCCAGUUAGUAGGAGUGCCACCUUCCUUUUCAAUAGUGGCGGUAAUUUU
AEJY01000029.1/421-243     GAGGACAGAAGUUUCUCGCAAUUAAAAUUUAUCAGCUUUACUUUCUGCUCUCUGGACACGCCUGCUUCUUUUUUCCCUGAGAGCAUUUUUUCGCAUUCCGAUUUGGUUAACUUUGU-UUUUGAGUACCUUGUCCAGUUAGUAGGAGUGCCACCUUCCUUUUCAAUUGUAGCGGUAAUUUU
#=GC SS_cons               :<<<<<<<<<<<<<__________>>>>>-->>>>>>>>,,((((((((--(((((,,,,,,<<<<-<<<________>>>>>>>,,,,<<<<---<<<<<__________>>>>>.--->>>>,,,,,,,)))))--))))))))<<<<<<______________>>>>>>::::::::
#=GC RF                    GaggaCcGaaguuuCUCGCAAUUAaaauuUAuCgGuucuACuuuCugCuCUCuGGaaACGccuGCuUCuuUUUUaCCugaGaGCaUUUUuuCgCAUuCugaUUUcGUUAauuuaGa.UUUuGaaUAuCUUGuCCaGUUaGuaGgagcGCCaCCUUCcUUUUCAAUAGuGGCgGUAAUUUU
//
